Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Other Non-Current Liabilities (2020 - 2025)

Historic Other Non-Current Liabilities for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to $38.0 million.

  • Maravai Lifesciences Holdings' Other Non-Current Liabilities fell 2999.24% to $38.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.0 million, marking a year-over-year decrease of 2999.24%. This contributed to the annual value of $52.5 million for FY2024, which is 1181.3% down from last year.
  • As of Q3 2025, Maravai Lifesciences Holdings' Other Non-Current Liabilities stood at $38.0 million, which was down 2999.24% from $38.2 million recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Other Non-Current Liabilities ranged from a high of $69.0 million in Q4 2022 and a low of $1.1 million during Q2 2021
  • Over the past 5 years, Maravai Lifesciences Holdings' median Other Non-Current Liabilities value was $54.0 million (recorded in 2024), while the average stood at $46.4 million.
  • Per our database at Business Quant, Maravai Lifesciences Holdings' Other Non-Current Liabilities soared by 468618.73% in 2022 and then tumbled by 2999.24% in 2025.
  • Maravai Lifesciences Holdings' Other Non-Current Liabilities (Quarter) stood at $41.1 million in 2021, then skyrocketed by 67.96% to $69.0 million in 2022, then dropped by 13.75% to $59.5 million in 2023, then fell by 11.81% to $52.5 million in 2024, then dropped by 27.63% to $38.0 million in 2025.
  • Its Other Non-Current Liabilities stands at $38.0 million for Q3 2025, versus $38.2 million for Q2 2025 and $44.0 million for Q1 2025.